CRISPR Therapeutics AG (CRSP)

CRISPR Therapeutics AG Revenue

CRISPR Therapeutics AG had revenue of $1.46M in the quarter ending March 31, 2026, with 68.55% growth. This brings the company's revenue in the last twelve months to $4.10M, down -89.11% year-over-year. In the year 2025, CRISPR Therapeutics AG had annual revenue of $3.51M, down -90.59%.

• Revenue (ttm): $4.10M
• Revenue Growth: -89.11%
• P/S Ratio: 1,141.49
• Revenue / Employee: $10,440
• Employees: 393
• Market Cap: 4.68B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.51M	-33.80M	-90.59%
Dec 31, 2024	37.31M	-333.89M	-89.95%
Dec 31, 2023	371.21M	370.01M	30,885.48%
Dec 31, 2022	1.20M	-913.77M	-99.87%
Dec 31, 2021	914.96M	914.24M	127,154.94%

Data Source: S&P Global Market Intelligence Last updated: May 4, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 15, 2026

Data Sources Report a data error